{"id":3752,"date":"2011-02-27T00:00:00","date_gmt":"2011-02-26T17:00:00","guid":{"rendered":"https:\/\/www.hivnat.org\/en\/?p=3752"},"modified":"2022-04-04T14:18:40","modified_gmt":"2022-04-04T07:18:40","slug":"18th-conference-on-retrovirus-and-opportunities-infections-croi-2011-held-on-february-27-march-2-2011-at-boston-ma-usa","status":"publish","type":"post","link":"https:\/\/www.hivnat.org\/en\/presentations\/3752\/","title":{"rendered":"18th Conference on Retrovirus and Opportunities Infections (CROI 2011) held on February 27 – March 2, 2011 at Boston, MA, USA"},"content":{"rendered":"\n
  1. Ananworanich J, Gorowara M, Avihingsanon A, van Heesch N, Kerr S, Khongpetch C, Uanithirat A, Hill A, Ruxrungtham K, and Burger D. Low-Dose RAL at 400 mg Once Daily Achieves Adequate Plasma Concentrations in HIV-1-infected Thai Patients<\/strong>. [Abstract # 649]
    http:\/\/retroconference.org\/2011\/PDFs\/649.pdf<\/a>
    http:\/\/f1000.com\/posters\/view\/document\/1089232<\/a> <\/li>
  2. Chokephaibulkit K, Prasitsuebsai W, Wittawatmongkol O, Gorowara M, Phongsamart W, Wongsabut J, Vanprapar N, Puthanakit T, Burger D, Ananworanich J on behalf of the HIV-NAT 113 Study Group. Pharmacokinetics of darunavir\/ritonavir in Asian HIV-1 infected children aged \u2265 6 years<\/strong>. [Poster # 714]
    http:\/\/www.retroconference.org\/2011\/PDFs\/714.pdf<\/a>
    http:\/\/f1000.com\/posters\/view\/document\/1089316<\/a><\/li>
  3. Crane M, Rajasuriar R, Avihingsanon A, Matthews G, Skinner N, Tangkitvanich P, Dore GJ, Visvanathan K, Ruxrungtham K, Lewin SR. LPS, immune activation and liver disease in HIV-HBV co-infection<\/strong>. [Poster # 937]
    http:\/\/retroconference.org\/2011\/PDFs\/937.pdf<\/a><\/li>
  4. Avihingsanon A, Praditpornsilpa K , Wongsabut J, Clark A, Kerr SJ, Ubolyam S, Phanuphak P, Ananworanich J, Hiransuthikul N, Ruxrungtham K and HIV-NAT 006 study team. Prevalence and prognostic factors of chronic kidney disease in HIV-infected patients, HIV-NAT 006 cohort, Thailand<\/strong>. [Poster # 843]
    http:\/\/www.natap.org\/2011\/CROI\/croi_70.htm<\/a>
    http:\/\/retroconference.org\/2011\/PDFs\/843.pdf<\/a><\/li>
  5. Bunupuradah T, Chetchotisakd P, Ananworanich J, Munsakul W, Jirajariyavet S, Kantipong P, Prasithsirikul W, Sungkanuparph S, Bowonwatanuwong C, Klinbuayaem V, Hirschel B, Bhakeecheep S, Ruxrungtham K and HIV STAR study team. Second line lopinavir\/ritonavir monotherapy was inferior to tenofovir\/lamivudine\/lopinavir\/ritonavir in patients who failed NNRTI-regimen: HIV STAR study<\/strong>. [Poster # 584]
    http:\/\/retroconference.org\/2011\/PDFs\/584.pdf<\/a>
    http:\/\/f1000.com\/posters\/view\/document\/1089259<\/a><\/li>
  6. Puthanakit T, Kerr S, Bunupuradah T, Aurpibul L, Taecharoenkul S, Sirisanthana V, Law M, and Ananworanich J. Slow accumulation of thymidine analog and etravirine-associated mutations in NNRTI treated children with virologic failure<\/strong>. [Poster # S-159]
    http:\/\/www.retroconference.org\/2011\/PDFs\/720.pdf<\/a>
    http:\/\/f1000.com\/posters\/view\/document\/1089264<\/a><\/li>
  7. Klinklom A, Puthanakit T, Gorowara M, Phasomsap C, Kerr S, Sriheara C, Ananworanich J, Burger D, Ruxrungtham K and Pancharoen C. Low Dose of Lopinavir\/ritonavir Achieves Adequate Pharmacokinetic Parameters in HIV-Infected Thai Children<\/strong>. [Abstract # S-119]
    http:\/\/www.retroconference.org\/2011\/PDFs\/709.pdf<\/a>
    http:\/\/f1000.com\/posters\/view\/document\/1089260<\/a><\/li><\/ol>\n","protected":false},"excerpt":{"rendered":"

    Ananworanich J, Gorowara M, Avihingsanon A, van Heesch N, Kerr S, Khongpetch C, Uanithirat A, Hill A, Ruxrungtham K, and Burger D. Low-Dose RAL at 400 mg Once Daily Achieves… <\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[66],"tags":[],"class_list":["post-3752","post","type-post","status-publish","format-standard","hentry","category-presentations"],"_links":{"self":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/3752","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/comments?post=3752"}],"version-history":[{"count":2,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/3752\/revisions"}],"predecessor-version":[{"id":3757,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/posts\/3752\/revisions\/3757"}],"wp:attachment":[{"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/media?parent=3752"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/categories?post=3752"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hivnat.org\/en\/wp-json\/wp\/v2\/tags?post=3752"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}